IRCT2015082323734N1已完成2 期
Evaluation of the effects of increasing tamoxifen dose based on CYP2D6 genotype on the endoxifen concentration and adverse events in breast cancer patients of Isfahan city
Isfahan University of Medical Siences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •Women were eligible if they were on tamoxifen 20 mg daily for at least 4 months; nonpregnant; had normal kidney, liver, and bone marrow function.
- •Patients were excluded if they had a concurrent medication therapy with medications known to
- •inhibit CYP2D6.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The influence of time of administration on tamoxifen pharmacokinetics.10006288Breast cancerNL-OMON39088Erasmus MC, Universitair Medisch Centrum Rotterdam18
撤回
不适用
The protective effect of tamoxifen in women with ER-positive breast cancer who opt for cryopreservation of oocytes or embryos: a prospectively controlled study.mammary carcinoma1000629110018515breast cancerNL-OMON36860Academisch Medisch Centrum40
尚未招募
2 期
A study involving comparison of the efficacy of TamoxifenVs Letrozole - two hormonal based drugs in treatment of male breast enlargementCTRI/2024/04/066186Institution Government Rajaji hospital madurai medical college
已完成
2 期
Comparison of adding Tamoxifen or Gonadotropin to Clomiphene for induction ovulation in Polycystic Ovary Syndrome (PCOS) patients resistance to ClomiphenePolycystic Ovary Syndrome.Polycystic Ovary SyndromeIRCT138904121760N8Vice Chancellor for Research and Technology, Babol University of Medical Sciences200
已完成
2 期
Assessment of the Efficacy of High-Dose Toremifene 120mg Therapy for Anastorozole-resistant Postmenopausal Breast Cancer (SBCCSG-11)Postmenopausal breast cancerJPRN-UMIN000000967Saitama Breast Cancer Clinical Study Group (SBCCSG)40